Logo image of SGMA

SIGMATRON INTERNATIONAL INC (SGMA) Stock Fundamental Analysis

NASDAQ:SGMA - Nasdaq - US82661L1017 - Common Stock - Currency: USD

1.06  +0.07 (+6.84%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SGMA. SGMA was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. SGMA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SGMA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SGMA had negative earnings in the past year.
In the past year SGMA had a positive cash flow from operations.
In multiple years SGMA reported negative net income over the last 5 years.
In multiple years SGMA reported negative operating cash flow during the last 5 years.
SGMA Yearly Net Income VS EBIT VS OCF VS FCFSGMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

SGMA has a Return On Assets of -7.59%. This is in the lower half of the industry: SGMA underperforms 62.90% of its industry peers.
Looking at the Return On Equity, with a value of -29.06%, SGMA is doing worse than 68.55% of the companies in the same industry.
SGMA has a Return On Invested Capital (1.96%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SGMA is above the industry average of 9.26%.
The 3 year average ROIC (11.58%) for SGMA is well above the current ROIC(1.96%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -7.59%
ROE -29.06%
ROIC 1.96%
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)11.58%
ROIC(5y)7.9%
SGMA Yearly ROA, ROE, ROICSGMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

With a Operating Margin value of 0.47%, SGMA perfoms like the industry average, outperforming 49.19% of the companies in the same industry.
SGMA's Operating Margin has improved in the last couple of years.
SGMA has a Gross Margin of 8.17%. This is amonst the worse of the industry: SGMA underperforms 82.26% of its industry peers.
In the last couple of years the Gross Margin of SGMA has remained more or less at the same level.
Industry RankSector Rank
OM 0.47%
PM (TTM) N/A
GM 8.17%
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
SGMA Yearly Profit, Operating, Gross MarginsSGMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SGMA is creating some value.
SGMA has more shares outstanding than it did 1 year ago.
SGMA has more shares outstanding than it did 5 years ago.
SGMA has a better debt/assets ratio than last year.
SGMA Yearly Shares OutstandingSGMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
SGMA Yearly Total Debt VS Total AssetsSGMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SGMA has an Altman-Z score of 1.90. This is not the best score and indicates that SGMA is in the grey zone with still only limited risk for bankruptcy at the moment.
SGMA has a worse Altman-Z score (1.90) than 67.74% of its industry peers.
SGMA has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as SGMA would need 2.92 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.92, SGMA is doing good in the industry, outperforming 70.16% of the companies in the same industry.
SGMA has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.09, SGMA perfoms like the industry average, outperforming 57.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.92
Altman-Z 1.9
ROIC/WACC0.19
WACC10.18%
SGMA Yearly LT Debt VS Equity VS FCFSGMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.16 indicates that SGMA should not have too much problems paying its short term obligations.
SGMA has a worse Current ratio (1.16) than 89.52% of its industry peers.
A Quick Ratio of 0.32 indicates that SGMA may have some problems paying its short term obligations.
SGMA's Quick ratio of 0.32 is on the low side compared to the rest of the industry. SGMA is outperformed by 95.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.32
SGMA Yearly Current Assets VS Current LiabilitesSGMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.64% over the past year.
SGMA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.22%.
SGMA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.17% yearly.
EPS 1Y (TTM)31.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33730.43%
Revenue 1Y (TTM)-15.22%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-24.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGMA Yearly Revenue VS EstimatesSGMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGMA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGMA Price Earnings VS Forward Price EarningsSGMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SGMA indicates a rather cheap valuation: SGMA is cheaper than 80.65% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than SGMA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.28
EV/EBITDA 9.03
SGMA Per share dataSGMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGMATRON INTERNATIONAL INC

NASDAQ:SGMA (4/17/2025, 8:00:02 PM)

1.06

+0.07 (+6.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-06 2025-03-06
Earnings (Next)09-01 2025-09-01
Inst Owners18.53%
Inst Owner Change0%
Ins Owners18.85%
Ins Owner Change0%
Market Cap6.49M
Analysts0
Price TargetN/A
Short Float %0.34%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.28
P/OCF 0.26
P/B 0.12
P/tB 0.12
EV/EBITDA 9.03
EPS(TTM)-2.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.73
FCFY351.82%
OCF(TTM)4.07
OCFY384.22%
SpS54.99
BVpS8.73
TBVpS8.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE -29.06%
ROCE 2.37%
ROIC 1.96%
ROICexc 2.08%
ROICexgc 2.11%
OM 0.47%
PM (TTM) N/A
GM 8.17%
FCFM 6.78%
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)11.58%
ROIC(5y)7.9%
ROICexc(3y)11.76%
ROICexc(5y)8.06%
ROICexgc(3y)12.49%
ROICexgc(5y)8.51%
ROCE(3y)14.02%
ROCE(5y)9.57%
ROICexcg growth 3Y42.8%
ROICexcg growth 5Y25.85%
ROICexc growth 3Y43.09%
ROICexc growth 5Y26.17%
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
F-Score5
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.92
Debt/EBITDA 0.62
Cap/Depr 34.48%
Cap/Sales 0.62%
Interest Coverage 0.16
Cash Conversion 325.29%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.32
Altman-Z 1.9
F-Score5
WACC10.18%
ROIC/WACC0.19
Cap/Depr(3y)59.02%
Cap/Depr(5y)70.3%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33730.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.22%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-24.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.47%
EBIT growth 3Y28.02%
EBIT growth 5Y18.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y164.65%
FCF growth 3Y97.89%
FCF growth 5YN/A
OCF growth 1Y174.63%
OCF growth 3Y50.77%
OCF growth 5YN/A